Loading...

Human TruStain FcX™ (Fc Receptor Blocking Solution)

Pricing & Availability
Regulatory Status
RUO
Other Names
Fc Blocker, FcγR blocker, Fc inhibitor
Ave. Rating
Submit a Review
Product Citations
publications
A_Human_TruStain_FcX_031110
Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant mouse IgG2a PE mAb (above). Dotted histogram represents unstained cells.
  • A_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (blue) or non-treated (red) THP-1 cells stained with an irrelevant rat IgG2b PE mAb (above). Dotted histogram represents unstained cells.
  • C_Human_TruStain_FcX_031110
    Human TruStain FcX™ treated (filled histograms) or non-treated (open histograms) THP-1 cells stained with anti-human HLA-DR PE (red) or an isotype control (IgG2a PE, blue) mAbs. Note: non-treated cells show false-negative HLA-DR staining due to high binding of mouse IgG2a isotype.
Cat # Size Price Quantity Check Availability Save
422301 50 tests 101 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
422302 200 tests 229 CHF
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Human Fc receptors (FcRs) are expressed on a variety of cells, such as monocytes, granulocytes, B cells and dendritic cells. The cells with FcR expression sometimes give false positive or false negative results of immunofluorescent staining due to the FcRs-mediated Ig Fc binding. Human TruStain FcX™ is specially formulated for blocking the FcR-involved unwanted staining without interfering with antibody-mediated specific staining of human cells. Human TruStain FcX™ is compatible with flow cytometric staining with anti-human CD16 (clone 3G8), CD32 (clone FUN-2), and CD64 (clone 10.1) antibodies.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
Store between 2°C and 8°C.
Application

FC - Quality tested
ICFC, ICC - Reported in the literature, not verified in house
Recommended Usage

It is recommended to add 5 µl of Human TruStain FcX™ per million cells in 100 µl staining volume, mix and incubate at room temperature for 5-10 minutes prior to staining with antibody of interest. It is not necessary to wash cells between these blocking and immunostaining steps.

Application Notes

This buffer contains specialized human IgG in PBS containing 0.09% sodium azide. It is not recommended to be used for staining human IgG. Handle as biohazard agent.

Application References

(PubMed link indicates BioLegend citation)
  1. de la Cruz J, et al. 2011. J. Immunol. 186:2282. PubMed
  2. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  3. Szerlip NJ, et al. 2012. PNAS. 109:3041. PubMed
  4. Bromley SK, et al. 2013. J. Immunol. 190:970. PubMed
  5. Trujilo G, et al. 2013. J. Immunol. 191:848. PubMed
  6. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  7. Euzebio Alves VT, et al. 2013. Infect Immun. 81:4399. PubMed
  8. Borg ZD, et al. 2014. J. Immunol. 192:189. PubMed
  9. Klingenberg R, et al. 2014. Eur Heart J. PubMed
  10. Lines JL, et al. 2014. Cancer Res. 74:1924. PubMed
  11. Decker D, et al. 2014. Lupus. 23:802. PubMed
  12. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  13. Anderson ME Jr, et al. 2014. Otolaryngol Head Neck Surg. 150:880. PubMed
  14. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  15. Shi J, et al. 2014. Blood. 123:4015. PubMed
  16. Kusner LL, et al. 2014. PLoS One. 9:102231. PubMed
  17. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  18. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  19. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  20. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  21. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  22. Vuong TT, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  23. Klingenberg R, et al. 2015. Eur Heart J. 36:1041. PubMed
  24. Wilkinson-Ryan I, et al. 2015. PLoS One.10:125851. PubMed
Product Citations
  1. Palacios-Arreola M, et al. 2017. Sci Rep. 10.1038/s41598-017-10135-1. PubMed
  2. Bahri R, et al. 2020. Methods Mol Biol. 2163:227. PubMed
  3. Liu T, et al. 2020. Biochem Biophys Res Commun. 532:385. PubMed
  4. McIlwain DR, et al. 2021. Cell Host Microbe. 29:1828. PubMed
  5. Alam A, et al. 2022. Cancer Cell. 40:153. PubMed
  6. Chang M, et al. 2022. Biotechnol Bioeng. 119:1820. PubMed
  7. Ioannidis LJ, et al. 2022. STAR Protoc. 3:101269. PubMed
  8. Glass MC, et al. 2022. Cell Rep. 39:110728. PubMed
  9. Mair F, et al. 2022. Nature. 605:728. PubMed
  10. Jou E, et al. 2022. Sci Immunol. 7:eabn0175. PubMed
  11. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  12. Jang HJ, et al. 2022. Cancer Res. 82:2593. PubMed
  13. Campisi L, et al. 2022. Nature. 606:945. PubMed
  14. Blanco LP, et al. 2022. Arthritis Rheumatol. 74:1971. PubMed
  15. Neely J, et al. 2022. Front Immunol. 13:902232. PubMed
  16. Feyaerts D, et al. 2022. Cell Rep Med. 3:100680. PubMed
  17. Werder RB, et al. 2022. Sci Adv. 8:eabo6566. PubMed
  18. Vazquez-Lombardi R, et al. 2022. Immunity. 55:1953. PubMed
  19. Calabrese DR, et al. 2022. JCI Insight. 7: . PubMed
  20. Scharf L, et al. 2023. JCI Insight. 8: . PubMed
  21. Messing M, et al. 2022. Front Immunol. 13:1010216. PubMed
  22. Wei H, et al. 2022. Front Immunol. 13:1060695. PubMed
  23. Wheeler MM, et al. 2022. Nat Commun. 13:7592. PubMed
  24. McEvoy CM, et al. 2022. Nat Commun. 13:7634. PubMed
  25. Shahid AM, et al. 2022. PLoS One. 17:e0278209. PubMed
  26. Kim JR, et al. 2022. Cancer Immunol Immunother. :. PubMed
  27. Wu VH, et al. 2023. Nat Immunol. 24:359. PubMed
  28. Stuart T, et al. 2022. Nat Biotechnol. :. PubMed
  29. Yang H, et al. 2023. Cell Death Differ. 30:560. PubMed
  30. Chow A 2023. Immunity. 56(1):93-106.e6. PubMed
  31. Asashima H, et al. 2023. Cell Rep. 42:111895. PubMed
  32. Sun W, et al. 2023. Nature. 614:309. PubMed
  33. Miller RA, et al. 2022. J Immunother Cancer. 10: . PubMed
  34. Heinen N, et al. 2023. Front Immunol. 13:1062210. PubMed
  35. Rice CM, et al. 2023. Life Sci Alliance. 6: . PubMed
  36. De Bakshi D, et al. 2023. Life Sci Alliance. 6: . PubMed
  37. Liao J, et al. 2023. Nat Commun. 14:207. PubMed
  38. Li Z, et al. 2022. J Thorac Dis. 14:4815. PubMed
  39. Poon MML, et al. 2023. Nat Immunol. 24:309. PubMed
  40. Wang CQ, et al. 2023. Cells. 12: . PubMed
  41. Mohamed H, et al. 2023. Biomedicines. 11: . PubMed
  42. Ty M, et al. 2023. Sci Transl Med. 15:eadd9012. PubMed
  43. Sadashivaiah V, et al. 2023. BMC Neurosci. 24:6. PubMed
  44. Gilman KE, et al. 2023. Front Immunol. 13:1045710. PubMed
  45. He T, et al. 2023. Immun Inflamm Dis. 11:e759. PubMed
  46. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  47. Di Benedetto C, et al. 2023. Cancers (Basel). 15: . PubMed
  48. Nandi I, et al. 2023. J Clin Invest. :. PubMed
  49. Chen SH, et al. 2022. Neurosci Bull. 38:290. PubMed
  50. Miller CL, et al. 2022. Cell Chem Biol. 29:451. PubMed
  51. Shen JZ, et al. 2022. Mol Cell. 82:1123. PubMed
  52. Gomez-Salinero JM, et al. 2022. Cell Stem Cell. 29:593. PubMed
  53. Jaiswal A, et al. 2022. Cancer Cell. 40:524. PubMed
  54. Knelson EH, et al. 2022. Cancer Immunol Res. 10:947. PubMed
  55. Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed
  56. Ferrall-Fairbanks MC, et al. 2022. Blood Cancer Discov. 3:536. PubMed
  57. Zhang X, et al. 2022. Cell Rep. 40:111363. PubMed
  58. Witkowski MT, et al. 2022. Nat Immunol. 23:1424. PubMed
  59. Gazinska P, et al. 2022. Clin Cancer Res. 28:4494. PubMed
  60. Li S, et al. 2022. Nature. 610:373. PubMed
  61. Xu Y, et al. 2022. Nat Genet. 54:1690. PubMed
  62. Ors A, et al. 2022. Nucleic Acids Res. 50:11492. PubMed
  63. Ainsua-Enrich E, et al. 2022. iScience. 25:105455. PubMed
  64. Deák P, et al. 2022. Cell Rep. 41:111563. PubMed
  65. Axelrod ML, et al. 2022. Nature. 611:818. PubMed
  66. Bowley TY, et al. 2022. Cancer Res Commun. 2:1436. PubMed
  67. Imanishi M, et al. 2022. Front Cardiovasc Med. 9:988713. PubMed
  68. Ye D, et al. 2023. Cell Mol Neurobiol. 43:2337. PubMed
  69. Lai ZZ, et al. 2023. Front Immunol. 14:992765. PubMed
  70. Long D, et al. 2023. Eur J Immunol. 53:e2250109. PubMed
  71. Lareau CA, et al. 2023. Nat Protoc. 18:1416. PubMed
  72. Jun SH, et al. 2023. Nat Commun. 14:982. PubMed
  73. Ryan FJ, et al. 2023. Cell Rep Med. 4:100971. PubMed
  74. Lakkis J, et al. 2022. Nat Mach Intell. 4:940. PubMed
  75. Clark IC, et al. 2023. Nat Biotechnol. . PubMed
  76. Thaweerattanasinp T, et al. 2023. PeerJ. 11:e14918. PubMed
  77. Ishikawa M, et al. 2023. Front Immunol. 14:998233. PubMed
  78. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  79. van Os BW, et al. 2023. Eur Heart J Open. 3:oead013. PubMed
  80. Yao L, et al. 2022. Cancer Res Commun. 2:1255. PubMed
  81. Vasaikar SV, et al. 2023. Nat Commun. 14:1684. PubMed
  82. Persad S, et al. 2023. Nat Biotechnol. . PubMed
  83. Gao F, et al. 2023. Immunity. 56:864. PubMed
  84. Pinto C, et al. 2023. iScience. 26:106381. PubMed
  85. Im KW, et al. 2023. NPJ Breast Cancer. 9:22. PubMed
  86. Wu T, et al. 2023. Nat Methods. 20:723. PubMed
  87. Luo Y, et al. 2023. Cell Discov. 9:40. PubMed
  88. Jiang Y, et al. 2023. Sci Adv. 9:eadc8933. PubMed
  89. Ito M, et al. 2023. Sci Rep. 13:5939. PubMed
  90. Woodley K, et al. 2023. Nat Commun. 14:2132. PubMed
  91. Liu Y, et al. 2023. Nat Commun. 14:2179. PubMed
  92. Thomas KA, et al. 2023. Transfusion. :S146. PubMed
  93. Boucher LE, et al. 2023. MAbs. 15:2195517. PubMed
  94. Lafôrets F, et al. 2023. iScience. 26:106514. PubMed
  95. Chen DY, et al. 2023. iScience. 26:106634. PubMed
  96. Solier S, et al. 2023. Nature. 617:386. PubMed
  97. Bera BS, et al. 2023. Epigenetics Chromatin. 16:14. PubMed
  98. Hu X, et al. 2023. Nat Biotechnol. . PubMed
  99. Luoma S, et al. 2023. Cancers (Basel). 15:. PubMed
  100. Lin W, et al. 2023. Commun Biol. 6:447. PubMed
  101. Wu C, et al. 2023. Cancer Metab. 11:7. PubMed
  102. Vokshi BH, et al. 2023. Nat Commun. 14:3034. PubMed
  103. Allard-Chamard H, et al. 2023. Cell Rep. 42:112630. PubMed
  104. Potts M, et al. 2023. Cell Rep. 42:112613. PubMed
  105. Diray-Arce J, et al. 2023. Cell Rep Med. 4:101079. PubMed
  106. Du J, et al. 2023. Nat Commun. 14:3675. PubMed
  107. Alber S, et al. 2022. Front Immunol. 13:838636. PubMed
  108. Lambert E, et al. 2022. Acta Neuropathol Commun. 10:4. PubMed
  109. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  110. Ptacin JL, et al. 2021. Nat Commun. 12:4785. PubMed
  111. Lau D, et al. 2022. Nat Commun. 13:4053. PubMed
  112. Sipe CJ, et al. 2022. Int J Mol Sci. 23:. PubMed
  113. Wanke F, et al. 2017. Cell Rep. 18(5):1270-1284. PubMed
  114. Ecker JW, et al. 2020. Vaccines (Basel). 8:00. PubMed
  115. Liu C, et al. 2021. Cell. 184(7):1836-1857.e22. PubMed
  116. Tsai AG, et al. 2020. Nat Med. 408:26. PubMed
  117. Argüello RJ, et al. 2020. Cell Metab. 32:1063. PubMed
  118. Aguilar EG, et al. 2021. Blood Adv. 5:4219. PubMed
  119. Klingenberg R, et al. 2014. Eur Heart J. . PubMed
  120. Fujisawa D, et al. 2014. J Allergy Clin Immunol. 134:622. PubMed
  121. Simon A, et al. 2015. Blood. 126: 378 - 385. PubMed
  122. Mitton B, et al. 2016. Leukemia. 10.1038/leu.2016.139. PubMed
  123. Chen X, et al. 2019. Exp Ther Med. 1.265972222. PubMed
  124. Fisher RC, et al. 2019. Neoplasia. 1.061805556. PubMed
  125. Winkler CW, et al. 2019. J Neuroinflammation. 0.825694444. PubMed
  126. O'Huallachain M, et al. 2020. Commun Biol. 3:213. PubMed
  127. Wartewig T, et al. 2017. Nature. . 10.1038/nature24649. PubMed
  128. Mehta P, et al. 2021. J Immunol. 207:1763. PubMed
  129. Lam B, et al. 2021. Cell Rep. 37:109838. PubMed
  130. de Cevins C, et al. 2021. Med (N Y). 2:1072. PubMed
  131. Gouin KH, et al. 2021. Nat Commun. 12:4906. PubMed
  132. Stanzione M, et al. 2022. Sci Adv. 8:eabn1229. PubMed
  133. Yoshida M, et al. 2022. Nature. 602:321. PubMed
  134. Egnuni T, et al. 2021. Pharmaceutics. 13:. PubMed
  135. Delvecchio FR, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1543. PubMed
  136. Jundi B, et al. 2021. JCI Insight. 6:e148866. PubMed
  137. Friebel E, et al. 2020. Cell. 181(7):1626-1642.e20. PubMed
  138. Ferrari de Andrade L, et al. 2020. Cancer Immunol Res. 0.867361111. PubMed
  139. Biasci D, et al. 2020. Proc Natl Acad Sci U S A. 117:28960. PubMed
  140. Glass DR, et al. 2020. Immunity. 53:217. PubMed
  141. Jackson S, et al. 2016. J Exp Med. 213: 733 - 750. PubMed
  142. Shin J, et al. 2016. Sci Rep. 6:23426. PubMed
  143. Vuong T, et al. 2015. J Histochem Cytochem. 63:280. PubMed
  144. Kusner L, et al. 2014. PLoS One. 9:102231. PubMed
  145. Starlard–Davenport A, et al. 2019. Br J Haematol. 186:91. PubMed
  146. Raju R, et al. 2017. Stem Cells Dev. 26:274. PubMed
  147. Kiritsy MC, et al. 2021. Elife. 10:. PubMed
  148. Rip J, et al. 2021. Bio Protoc. 11:e3902. PubMed
  149. Cluff E, et al. 2022. Cancer Immunol Immunother. . PubMed
  150. Mylka V, et al. 2022. Genome Biol. 23:55. PubMed
  151. Jairaman A, et al. 2022. Elife. 11:. PubMed
  152. Takano T, et al. 2022. Cell Rep Med. 3:100631. PubMed
  153. Vinjamur DS, et al. 2021. Nat Genet. 53:719. PubMed
  154. Judge SJ, et al. 2022. Front Immunol. 13:893177. PubMed
  155. Lo MW, et al. 2022. Clin Transl Immunology. 11:e1413. PubMed
  156. Masuda K, et al. 2022. JCI Insight. 7:. PubMed
  157. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  158. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  159. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  160. Nielsen CM, et al. 2021. Cell Reports Medicine. 2(3):100207. PubMed
  161. Goveia J, et al. 2020. Cancer Cell. 21:37. PubMed
  162. Lee E, et al. 2021. Sci Rep. 11:14841. PubMed
  163. Doerflinger M, et al. 2021. Clin Transl Immunology. 10:e1235. PubMed
  164. Chen L, et al. 2021. Int J Mol Sci. 22:. PubMed
  165. Chen GM, et al. 2021. Cancer Discov. 11:2186. PubMed
  166. Trujillo G, et al. 2013. J Immunol. 191:848. PubMed
  167. Karagiannis TT, et al. 2020. Nat Commun. 2.271527778. PubMed
  168. Li Z, et al. 2018. Exp Ther Med. 3.410416667. PubMed
  169. Mayer RL, et al. 2022. Nat Commun. 13:6075. PubMed
  170. Cook CP, et al. 2022. Cell Rep Med. 3:100715. PubMed
  171. Zhou WH, et al. 2022. Discov Oncol. 13:67. PubMed
  172. Wang M, et al. 2022. Immun Inflamm Dis. 10:e626. PubMed
  173. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  174. Pérez-Pérez S, et al. 2022. Biomedicines. 10:. PubMed
  175. Figueroa-Romero C, et al. 2022. Front Immunol. 13:773288. PubMed
  176. Chen X, et al. 2022. Front Immunol. 12:807134. PubMed
  177. Emmons TR, et al. 2021. Cancer Immunol Res. 9:790. PubMed
  178. Snyder ME, et al. 2021. Am J Respir Crit Care Med. 203:1230. PubMed
  179. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  180. Gupta S, et al. 2020. Proc Natl Acad Sci U S A. 117:16481. PubMed
  181. AC Belkina, JE Snyder-Cappione 2017. Cytometry A. 91:175-179. PubMed
  182. Lindgren I, et al. 2016. Hum Reprod. 31: 672 - 683. PubMed
  183. Beljanski V, et al. 2015. J Virol. 89: 10612 - 10624. PubMed
  184. Pontarini E, et al. 2015. Rheumatology. 54: 1429-1434. PubMed
  185. Feng WW, et al. 2019. Cell Rep. 29:3405. PubMed
  186. Wright AKA, et al. 2017. J Allergy Clin Immunol. 140:1430. PubMed
  187. Wang L, et al. 2022. Theranostics. 12:7216. PubMed
  188. Pickering H, et al. 2021. JCI Insight. 6:. PubMed
  189. Nugent JL, et al. 2021. iScience. 24:103421. PubMed
  190. Chen Z, et al. 2022. J Nanobiotechnology. 20:30. PubMed
  191. Ogbe A, et al. 2022. JCI Insight. . PubMed
  192. Sun V, et al. 2021. Front Immunol. 12:716661. PubMed
  193. Andrews JM, et al. 2021. EBioMedicine. 71:103559. PubMed
  194. Apostolidis SA, et al. 2022. Front Immunol. 13:834988. PubMed
  195. Woodruff MC, et al. 2022. Nature. :. PubMed
  196. Shi Z, et al. 2021. Ann Clin Transl Neurol. 8:43. PubMed
  197. Woodruff MC, et al. 2020. Nat Immunol. 1.920833333. PubMed
  198. Wang E, et al. 2021. Cell Stem Cell. 28(4):718-731.e6. PubMed
  199. Harris MJ, et al. 2021. Mol Syst Biol. 17:e10091. PubMed
  200. Liu C, et al. 2021. Cell Res. 31:1106. PubMed
  201. Jama B, Morris G 2014. J Vis Exp. 93: 52257. PubMed
  202. Patera A, et al. 2016. J Leukoc Biol. 100(6):1239-1254. PubMed
  203. Al–Marsoummi S, et al. 2019. Cell Physiol Biochem. 53:999. PubMed
  204. Weisberg SP, et al. 2020. Cell Reports. 29(12):3916-3932.e5.. PubMed
  205. Seamon K, et al. 2020. Front Immunol. 11:396. PubMed
  206. Gao X, et al. 2017. PLoS One. 10.1371/journal.pone.0189167. PubMed
  207. Dashtsoodol N, et al. 2017. Front Immunol. 10.3389/fimmu.2017.01206. PubMed
  208. Deng H, et al. 2017. Arthritis Res Ther. 10.1186/s13075-017-1339-4. PubMed
  209. Kumar V, et al. 2022. Cells. 11:. PubMed
  210. Burnett CE, et al. 2022. Immunity. 55:1284. PubMed
  211. Calianese D, et al. 2021. J Immunol. 207:436. PubMed
  212. Ma YV, et al. 2021. MAbs. 13:2003281. PubMed
  213. Vijayakumar B, et al. 2022. Immunity. . PubMed
  214. Pérez-Pérez S, et al. 2021. Front Immunol. 12:798003. PubMed
  215. Chan JM, et al. 2021. Cancer Cell. 39:1479. PubMed
  216. Hendricks A, et al. 2021. Front Oncol. 11:646885. PubMed
  217. Toulmin SA, et al. 2021. Nat Commun. 12:3993. PubMed
  218. Stephenson E, et al. 2021. Nat Med. 27:904. PubMed
  219. Layer JV, et al. 2020. Proc Natl Acad Sci U S A. 27566:117. PubMed
  220. Dogra P, et al. 2020. Cell. 749:180. PubMed
  221. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  222. Linke M, et al. 2017. Nat Immunol. 18:293-302. PubMed
  223. Ciarlo E, et al. 2016. Sci Rep. 6:37944. PubMed
  224. Vir P, et al. 2015. PLoS One. 10: 0144904. PubMed
  225. Fuentes I, et al. 2020. Sci Rep. 10:15064. PubMed
  226. Stuart T, et al. 2019. Cell. 177:1888. PubMed
  227. Worwa G, et al. 2022. Commun Biol. 5:1204. PubMed
  228. Sen K, et al. 2021. Front Immunol. 12:733539. PubMed
  229. Zheng S, et al. 2022. Blood Cancer Discov. 3:103. PubMed
  230. Quinn TM, et al. 2022. EBioMedicine. 76:103856. PubMed
  231. Vanshylla K, et al. 2022. Cell Host Microbe. 30:69. PubMed
  232. Bowen J, et al. 2017. PLoS Pathog. 13(2):e1006164. PubMed
  233. Kreutmair S, et al. 2021. Immunity. . PubMed
  234. Rapiteanu R, et al. 2020. Eur Respir J. :55. PubMed
  235. Harrison TE, et al. 2020. Nature. 309:587. PubMed
  236. Poonpanichakul T, et al. 2021. Front Immunol. 12:599805. PubMed
  237. Decker D, et al. 2014. Lupus. 123:2663. PubMed
  238. Lisovsky I, et al. 2015. J Virol. 89: 9909 - 9919. PubMed
  239. Busch S, et al. 2016. J Immunol. 197(11):4493-4503. PubMed
  240. Zhang W, et al. 2019. Exp Ther Med. 2.490972222. PubMed
  241. Bocharnikov AV, et al. 2019. JCI Insight. 4:e126832. PubMed
  242. Mair F, et al. 2020. Cell Rep. 31:107499. PubMed
  243. Abrecht C, et al. 2022. STAR Protoc. 3:101362. PubMed
  244. Lai ZZ, et al. 2020. Am J Reprod Immunol. 84:e13295. PubMed
  245. Adamik J, et al. 2022. Nat Commun. 13:5184. PubMed
  246. Romine KA, et al. 2021. Blood Cancer Discov. 2:518. PubMed
  247. Vanuytsel K, et al. 2022. Nat Commun. 13:1103. PubMed
  248. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  249. Muir LA, et al. 2022. JCI Insight. 7:. PubMed
  250. Romine KA, et al. 2021. Cancer Discov. . PubMed
  251. Rogers BM, et al. 2021. J Exp Med. 218:. PubMed
  252. Shen Z, et al. 2021. iScience. 24:103014. PubMed
  253. Wu CL, et al. 2021. Nat Commun. 12:362. PubMed
  254. Qiu XM, et al. 2020. Reproduction. 251:159. PubMed
  255. Gonzalez VD, et al. 2021. Cell Reports. 36(9):109632. PubMed
  256. Obradovic A, et al. 2021. Cell. 184(11):2988-3005.e16. PubMed
  257. Russ K, et al. 2021. Cell Reports. 34(12):108895. PubMed
  258. Marjanovic ND, et al. 2020. Cancer Cell. 38(2):229-246.e13. PubMed
  259. Judge SJ, et al. 2020. J Clin Invest. 130:3051. PubMed
  260. Market M, et al. 2020. Front Immunol. 1.127083333. PubMed
  261. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  262. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  263. Jitschin R, et al. 2014. Blood. 123:2663. PubMed
  264. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  265. Souriant S, et al. 2019. Cell Rep. 26:3586. PubMed
  266. Riordon DR, et al. 2017. Methods Mol Biol. 1722:127. PubMed
  267. Weaver JD, et al. 2022. Oncoimmunology. 11:2141007. PubMed
  268. Du Y, et al. 2022. Nat Commun. 13:231. PubMed
  269. Painter MM, et al. 2021. Immunity. 54:2133. PubMed
  270. Syrimi E, et al. 2021. iScience. 24:103215. PubMed
  271. Thijssen R, et al. 2022. Blood. :. PubMed
  272. Good Z, et al. 2022. Nat Med. :. PubMed
  273. Ferrer-Font L, et al. 2021. Curr Protoc. 1:e222. PubMed
  274. Le BV, et al. 2020. Cell Rep. 33:108221. PubMed
  275. Venturutti L, et al. 2020. Cell. 182(2):297-316.e27. PubMed
  276. Lu Q, et al. 2021. Immunity. 54(6):1304-1319.e9. PubMed
  277. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  278. Helmink BA, et al. 2020. Nature. 577:549. PubMed
  279. Cao Y, et al. 2021. Cell Res. 31:732. PubMed
  280. Wang W, et al. 2021. Clin Transl Med. 11:e253. PubMed
  281. Wang YC, et al. 2021. Nat Commun. 12:3530. PubMed
  282. Edin S, et al. 2013. PLoS One. 18:74982. PubMed
  283. Borg Z, et al. 2014. J Immunol. 192:189. PubMed
  284. Shi J, et al. 2014. Blood. 123:4015. PubMed
  285. Galvani S, et al. 2015. Sci Signal. 8: ra79. PubMed
  286. Boyerinas B, et al. 2015. Cancer Immunol Res. 3: 1148 - 1157. PubMed
  287. Zabransky DJ, et al. 2015. Proc Natl Acad Sci U S A. 112: 6205 -6214. PubMed
  288. Thorek D, et al. 2016. Sci Transl Med. 8: 367ra167. PubMed
  289. Poon E, et al. 2017. J Immunother Cancer. 10.1186/s40425-017-0268-8. PubMed
  290. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  291. Chen Y, et al. 2022. Front Immunol. 13:835690. PubMed
  292. Zeng Q, et al. 2022. Front Immunol. 13:740805. PubMed
  293. Jiang Y, et al. 2020. Br J Pharmacol. . PubMed
  294. Opzoomer JW, et al. 2021. Elife. :10. PubMed
  295. Woodruff M, et al. 2020. medRxiv. . PubMed
  296. Nabet BY, et al. 2020. Cell. 183(2):363-376.e13. PubMed
  297. Zobel MJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  298. Seifert L, et al. 2015. Cell Rep. 13: 1909-1921. PubMed
  299. Punyadee N, et al. 2015. J Virol. 89:1587. PubMed
  300. Yoon J, et al. 2020. Front Cell Dev Biol. 0.520138889. PubMed
  301. Studniberg SI, et al. 2022. Mol Syst Biol. 18:e10824. PubMed
  302. Huang Y, et al. 2022. iScience. 25:105209. PubMed
  303. Quintanal-Villalonga A, et al. 2022. STAR Protoc. 3:101776. PubMed
  304. Liu Y, et al. 2022. Front Oncol. 12:1037934. PubMed
  305. Besnier M, et al. 2021. Antioxidants (Basel). 10:. PubMed
  306. Dugger DT, et al. 2021. Front Immunol. 12:704172. PubMed
  307. Vick SC, et al. 2021. Sci Adv. 7:eabj0274. PubMed
  308. Hu Y, et al. 2021. Am J Hum Genet. 108:874. PubMed
  309. Levi H, et al. 2022. J Exp Med. 219:. PubMed
  310. Jorapur A, et al. 2022. PLoS Pathog. 18:e1010200. PubMed
  311. Trevelin SC, et al. 2022. Front Immunol. 13:838328. PubMed
  312. Sureshchandra S, et al. 2022. Cell Rep. 39:110938. PubMed
  313. Ndeupen S, et al. 2021. iScience. 24:103479. PubMed
  314. Zhu S, et al. 2022. J Oncol. 2022:8724933. PubMed
  315. Gadi D, et al. 2022. Leukemia. 36:723. PubMed
  316. Burns JC, et al. 2020. eLife. 9:00. PubMed
  317. Herati RS, et al. 2021. Cell Reports Medicine. 2(5):100262. PubMed
  318. Ziegler CGK, et al. 2021. Cell. 184(18):4713-4733.e22. PubMed
  319. An Y, et al. 2021. Sci Rep. 6392:11. PubMed
  320. Chen G, et al. 2021. Signal Transduct Target Ther. 6:289. PubMed
  321. Giurisato E, et al. 2014. Mol Biol Cell. 25:1769. PubMed
  322. Lundholm M, et al. 2015. Sci Rep. 5: 15651. PubMed
  323. Revelo X, et al. 2016. Cell Rep. 16: 717-730. PubMed
  324. Thomas K, et al. 2016. J Leukoc Biol. 100: 177 - 184. PubMed
  325. Zhu Y, et al. 2019. Cell Stem Cell. 25:542. PubMed
  326. Reustle A, et al. 2022. Clin Transl Med. 12:e883. PubMed
  327. Bahcecioglu G, et al. 2021. Adv Sci (Weinh). 8:e2100128. PubMed
  328. Li G, et al. 2021. Curr Protoc. 1:e50. PubMed
  329. Anadon CM, et al. 2022. STAR Protoc. 3:101649. PubMed
  330. Nadeu F, et al. 2022. Nat Med. 28:1662. PubMed
  331. Hirschberger S, et al. 2022. Front Med (Lausanne). 9:923502. PubMed
  332. Pathania AS, et al. 2022. Mol Ther Oncolytics. 25:308. PubMed
  333. Wang J, et al. 2022. iScience. 25:103971. PubMed
  334. Wu Y, et al. 2022. J Cancer Res Clin Oncol. . PubMed
  335. Woolley CR, et al. 2022. Immunohorizons. 6:47. PubMed
  336. Wendisch D, et al. 2021. Cell. 184:6243. PubMed
  337. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  338. Poon MML, et al. 2021. Cell Rep. 37:110071. PubMed
  339. Henrich IC, et al. 2021. Cancer Res. 81:2171. PubMed
  340. Wegner J, et al. 2021. Sci Rep. 11:14983. PubMed
  341. Sun L, et al. 2021. Sci Rep. 11:12477. PubMed
  342. Li H, et al. 2021. Adv Sci (Weinh). 2001596:8. PubMed
  343. OConnor RA, et al. 2021. OncoImmunology. 10(1):1940675. PubMed
  344. Cheng Y, et al. 2021. Immunity. 54(8):1825-1840.e7. PubMed
  345. Glassman CR, et al. 2021. Cell. 184(4):983-999.e24. PubMed
  346. Zeng J, et al. 2020. Nat Med. 26:535. PubMed
  347. Wang C, et al. 2015. Clin Immunol. 159: 47-57. PubMed
  348. Luo L, et al. 2011. Exp Mol Pathol. 91:596. PubMed
  349. Cruz J, et al. 2011. J Immunol. 186:2282. PubMed
  350. Qin XH, et al. 2019. Langmuir. 35:1882. PubMed
  351. Song M, et al. 2018. Nature. 562:423. PubMed
  352. Cortés-López M, et al. 2022. Nat Commun. 13:5570. PubMed
  353. LaSalle TJ, et al. 2022. Cell Rep Med. 3:100779. PubMed
  354. Li YR, et al. 2021. Cell Rep Med. 2:100449. PubMed
  355. Mudd PA, et al. 2022. Cell. 185:603. PubMed
  356. Kusi M, et al. 2022. Cell Rep. 38:110220. PubMed
  357. Dahal S, et al. 2022. Retrovirology. 19:18. PubMed
  358. Stephanie Elizabeth, Johanna Zandee 2017. Immunol Cell Biol. 10.1038/icb.2017.3. PubMed
  359. Morales Pantoja IE, et al. 2020. PLoS One. 15:e0233980. PubMed
  360. Huetter J, et al. 2020. Cancer Immunol Res. 0.954861111. PubMed
  361. Still C 2nd, et al. 2021. Cell Reports Medicine. 2(7):100343. PubMed
  362. Feng W, et al. 2020. J Vis Exp. . PubMed
  363. Hannon E, et al. 2021. PLoS Genet. e1009443:17. PubMed
  364. Tsuboki J, et al. 2016. Sci Rep. 6:29588. PubMed
  365. Gao M, et al. 2016. Sci Rep. 6:29955. PubMed
  366. Good Z, et al. 2019. Nat Biotechnol. 37:259. PubMed
  367. Xue J, et al. 2020. Arthritis Res Ther. 1.070138889. PubMed
  368. Oetjen KA, et al. 2018. JCI Insight. 3:e124928. PubMed
  369. Jiang X, et al. 2018. Cell Mol Immunol. 1.338194444. PubMed
  370. Gov L,et al. 2017. J Immunol. 10.4049/jimmunol.1700245. PubMed
  371. Metcalf T, et al. 2017. J Immunol. 10.4049/jimmunol.1700148. PubMed
  372. Huang D, et al. 2022. Cell Discov. 8:121. PubMed
  373. Shemesh A, et al. 2022. J Exp Med. 219:. PubMed
  374. Michelozzi IM, et al. 2022. STAR Protoc. 3:101174. PubMed
  375. Lo YC, et al. 2022. Nat Commun. 13:934. PubMed
  376. Thakkar D, et al. 2022. J Immunother Cancer. 10:. PubMed
  377. Erickson JR, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  378. Wang X, et al. 2022. J Immunol. 208:396. PubMed
  379. Fang F, et al. 2021. Cell Rep. 37:109981. PubMed
  380. Paul S, et al. 2021. Sci Transl Med. 13:. PubMed
  381. Combes AJ, et al. 2021. Nature. 591:124. PubMed
  382. Larson-Casey JL, et al. 2020. PLoS One. 15:e0241323. PubMed
  383. Carmona-Rivera C, et al. 2020. JCI Insight. 5:00. PubMed
  384. Surendran N, et al. 2016. Innate Immunity. 22: 63 - 71. PubMed
  385. Lines J, et al. 2014. Cancer Res. 74:1924. PubMed
  386. Alves V, et al. 2013. Infect Immun . 81:4399. PubMed
  387. Ellyard JI, et al. 2019. Front Immunol. 1.898611111. PubMed
  388. Fan C, et al. 2019. Mol Med Rep. 3.002083333. PubMed
  389. Franco LM, et al. 2019. J Exp Med. 216:384. PubMed
  390. Guo JJ, et al. 2017. Exp Ther Med. 3.842361111. PubMed
  391. López-Sanz C, et al. 2022. STAR Protoc. 3:101755. PubMed
  392. Liao M, et al. 2021. Aging (Albany NY). 13:22412. PubMed
  393. Gutierrez C, et al. 2021. Nat Cancer. 2:758. PubMed
  394. Georg P, et al. 2022. Cell. 185:493. PubMed
  395. Céspedes PF, et al. 2022. Nat Commun. 13:3460. PubMed
  396. Zhang F, et al. 2021. Genome Med. 13:64. PubMed
  397. Luque-Martin R, et al. 2021. J Immunol. 207:555. PubMed
  398. Li F, et al. 2022. Nat Commun. 13:4334. PubMed
  399. Rydyznski Moderbacher C, et al. 2022. J Clin Invest. :. PubMed
  400. Hwang B, et al. 2021. Nat Methods. 18:903. PubMed
  401. Montel-Hagen A, et al. 2022. Curr Protoc. 2:e403. PubMed
  402. Kirabo A, et al. 2017. J Mol Cell Cardiol. 10.1016/j.yjmcc.2017.03.001. PubMed
  403. Judge SJ, et al. 2020. J Immunother Cancer. 8:00. PubMed
  404. Greenlee JD, et al. 2021. eLife. 0.416666666666667. PubMed
  405. Herland A, et al. 2020. Nat Biomed Eng. 421:4. PubMed
  406. Hepprich M, et al. 2020. Cell Metab. 699:31. PubMed
  407. Demaree B, et al. 2021. Nat Commun. 1583:12. PubMed
  408. Hoffmann J, et al. 2021. Nat Commun. 12:3964. PubMed
  409. Zhang X, et al. 2021. Nat Commun. 12:4536. PubMed
  410. Hirschberger S, et al. 2021. EMBO Mol Med. 13:e14323. PubMed
  411. Lieber S, et al. 2014. Mol Pharmacol. 87:162. PubMed
  412. Page K, et al. 2015. J Pharmacol Exp Ther. 355: 199 - 205. PubMed
  413. Wanke-Jellinek L, et al. 2016. J Immunol. 196: 767 - 777. PubMed
  414. Schneeberger V, et al. 2016. PLoS One. 11: 0160587. PubMed
  415. Maini A, et al. 2016. PLoS One. 11:e0165502. PubMed
  416. Burel J, et al. 2016. PLoS Negl Trop Dis. 10:e0005031. PubMed
  417. Zhao Y, et al. 2020. Immunity. 51(6):1059-1073.e9.. PubMed
  418. Nobre LV, et al. 2020. eLife. 8:e49894.. PubMed
  419. Szerlip N, et al. 2012. Proc Natl Acad Sci U S A. 109:3041. PubMed
  420. Bromley S, et al. 2013. J Immunol. 190:970. PubMed
  421. Bricio–Moreno L, et al. 2018. Nat Commun. 2.204861111. PubMed
  422. Arrigucci R, et al. 2017. Nat Protoc. 1.364583333. PubMed
  423. Strazza M, et al. 2022. Mol Ther Methods Clin Dev. 27:380. PubMed
  424. Konkimalla A, et al. 2022. iScience. 25:105114. PubMed
  425. Tang JS, et al. 2022. Front Immunol. 13:946713. PubMed
  426. Liu Y, et al. 2022. Clin Transl Med. 12:e654. PubMed
  427. Ruan LY, et al. 2022. Biomolecules. 12:. PubMed
  428. Lederer K, et al. 2022. Cell. . PubMed
  429. Wang YM, et al. 2022. Oncoimmunology. 11:2034257. PubMed
  430. Jiang J, et al. 2021. Front Immunol. 12:785549. PubMed
  431. Yang Y, et al. 2021. Emerg Microbes Infect. 10:905. PubMed
  432. Shuwa HA, et al. 2021. Med. 2(6):720-735.e4. PubMed
  433. Landgraf KE, et al. 2020. Commun Biol. 0.330555556. PubMed
  434. Nahid M, et al. 2016. J Leukoc Biol. 100: 339 - 349. PubMed
  435. Eichten A, et al. 2016. Cancer Res . 76: 2327-2339. PubMed
  436. Wierzbinska JA, et al. 2020. Genome Med. 12:29. PubMed
  437. Sade–Feldman M, et al. 2018. Cell. 175:998. PubMed
  438. Kubala MH, et al. 2018. Cell Rep. 25:2177. PubMed
  439. Delgado-Gonzalez A, et al. 2022. STAR Protoc. 3:101425. PubMed
  440. Chou DB, et al. 2022. Nat Commun. 13:6021. PubMed
  441. Pauken CM, et al. 2021. Cancers (Basel). 13:. PubMed
  442. Genge PC, et al. 2021. STAR Protoc. 2:100900. PubMed
  443. Winkler C, et al. 2021. JCI Insight. 6:. PubMed
  444. Adamo S, et al. 2022. Nature. 602:148. PubMed
  445. Krijgsman D, et al. 2022. STAR Protoc. 3:101034. PubMed
  446. Hallisey M, et al. 2022. STAR Protoc. 3:101163. PubMed
  447. Konishi S, et al. 2022. STAR Protoc. 3:101447. PubMed
  448. Galván-Peña S, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  449. Wilson TL, et al. 2022. Cancer Discov. 12:2098. PubMed
  450. Claireaux MAF, et al. 2022. Nat Commun. 13:4539. PubMed
  451. Allard-Chamard H, et al. 2021. J Immunol. 206:524. PubMed
  452. Maas RR, et al. 2021. Nat Protoc. 16:4692. PubMed
  453. Mujal AM, et al. 2022. Cancer Immunol Res. 10:403. PubMed
  454. Festag J, et al. 2020. Mol Ther Nucleic Acids. 1.330555556. PubMed
  455. Maehara T, et al. 2020. J Clin Invest. 130:2451. PubMed
  456. Mathewson ND, et al. 2021. Cell. 184(5):1281-1298.e26. PubMed
  457. Szodoray P, et al. 2021. Cell Reports. 36(6):109525. PubMed
  458. Jin HS, et al. 2020. Cancer Immunol Res. 8:912. PubMed
  459. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  460. Rovira-Clavé X, et al. 2021. Nat Commun. 12:4628. PubMed
  461. Wurm M, et al. 2021. Mol Cancer Ther. 20:2250. PubMed
  462. Bhardwaj N, et al. 2014. J Virol. 88:11108. PubMed
  463. Olagnier D, et al. 2014. PLoS Pathog. 10:1004566. PubMed
  464. Wilkinson-Ryan I, et al. 2015. PLoS One. 10:125851. PubMed
  465. Ali A, et al. 2015. PLoS One. 10: 0131645. PubMed
  466. Kanzaki H, et al. 2016. Sci Rep. 6:32259. PubMed
  467. Goehring K, et al. 2016. J Nutr. 146(12):2559-2566. PubMed
  468. Wu X, et al. 2020. Front Immunol. 1.922222222. PubMed
  469. Yang ZZ, et al. 2019. Cell Rep. 26:2178. PubMed
  470. Olafsdottir TA, et al. 2022. Commun Biol. 5:914. PubMed
  471. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  472. Alhussan A, et al. 2022. Cancers (Basel). 14:. PubMed
  473. Lee PC, et al. 2022. J Clin Invest. 132:. PubMed
  474. Rouhani SJ, et al. 2022. J Immunother Cancer. 10:. PubMed
  475. Chan M, et al. 2021. Mol Syst Biol. 17:e10426. PubMed
  476. Rodríguez-Lorenzo S, et al. 2022. Elife. 11:. PubMed
  477. Vechetti IJ, et al. 2021. FASEB J. 35:e21644. PubMed
  478. Manríquez V, et al. 2021. Nat Commun. 12:4547. PubMed
  479. Tomita T, et al. 2021. Nat Commun. 12:3655. PubMed
  480. Salahudeen AA, et al. 2020. bioRxiv. . PubMed
  481. Qi J, et al. 2021. Cell Reports Medicine. 2(8):100353. PubMed
  482. Hara T, et al. 2021. Cancer Cell. 39(6):779-792.e11. PubMed
  483. Clayton KL, et al. 2021. Cell Host Microbe. 29(3):435-447.e9. PubMed
  484. Nielsen S, et al. 2016. Nat Cell Biol. 18: 549-560. PubMed
  485. Jarantow S, et al. 2015. J Biol Chem. 290: 24689 - 24704. PubMed
  486. Anderson M, et al. 2014. Otolaryngology Head Neck Surg. 150:880. PubMed
  487. Sontheimer-Phelps A, et al. 2019. Cell Mol Gastroenterol Hepatol. 9:507. PubMed
  488. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  489. Cai Q, et al. 2019. Oncol Lett. 2.967361111. PubMed
  490. Lynskey N, et al. 2017. PLoS Pathog.. 10.1371/journal.ppat.1006493. PubMed
  491. Eitas T, et al. 2017. PLoS One. 10.1371/journal.pone.0184164. PubMed
  492. Ainsworth RI, et al. 2022. Nat Commun. 13:6221. PubMed
  493. Chen C, et al. 2022. iScience. 25:103645. PubMed
  494. Lu J, et al. 2022. STAR Protoc. 3:101559. PubMed
  495. MacBride M, et al. 2017. Mammalian Genome. 10.1007/s00335-017-9680-0. PubMed
  496. Chou DB, et al. 2020. Nat Biomed Eng. 0.440277778. PubMed
  497. Nistler R, et al. 2020. Immunohorizons. 0.397222222. PubMed
  498. Pettmann J, et al. 2021. eLife. 10:00. PubMed
  499. Luoma AM, et al. 2020. Cell. 182(3):655-671.e22. PubMed
  500. Perugino CA, et al. 2021. J Allergy Clin Immunol. 368:147. PubMed
  501. Shaw BC, et al. 2021. CRISPR J. 4:699. PubMed
  502. Pleguezuelos O, et al. 2015. Clin Vaccine Immunol. 22: 828 - 835. PubMed
  503. Alasoo K, et al. 2015. Sci Rep. 5: 12524. PubMed
  504. Burel J, et al. 2016. PLoS Pathog. 12: 1005839. PubMed
  505. Verma SK, et al. 2018. J Biol Chem. 293:254. PubMed
  506. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed
  507. Itoh H, et al. 2017. J Vet Med. 10.1155/2017/5701016. PubMed
  508. Kamada R, et al. 2017. The Journal of Biochemistry. 10.1093/jb/mvx032. PubMed
  509. Yao W, et al. 2017. Molecular Immunology. 10.1016/j.molimm.2017.04.017. PubMed
  510. Jeong HO, et al. 2022. iScience. 25:105358. PubMed
  511. Murphy DM, et al. 2022. J Clin Invest. Online ahead of print. PubMed
  512. Faissner S, et al. 2022. Front Immunol. 13:980526. PubMed
  513. Zha Y, et al. 2022. Front Immunol. 13:877314. PubMed
  514. Wang H, et al. 2022. J Cancer. 13:2126. PubMed
  515. Medeiros-Furquim T, et al. 2022. Front Immunol. 13:678817. PubMed
  516. Kaya-Tilki E, et al. 2021. PLoS One. 16:e0260633. PubMed
  517. Kämpe A, et al. 2021. PLoS One. 16:e0257442. PubMed
  518. Pinto SM, et al. 2021. Front Immunol. 12:679458. PubMed
  519. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
  520. Wang EY, et al. 2021. Nature. 595:283. PubMed
  521. Mpakou V, et al. 2021. Exp Ther Med. 1.010416667. PubMed
  522. Scharenberg SG, et al. 2020. Nat Commun. 2.76875. PubMed
  523. Sainson RCA, et al. 2020. Cancer Immunol Res. 1.422222222. PubMed
  524. Salahudeen AA, et al. 2020. Nature. 588:670. PubMed
  525. Okamura Y, et al. 2017. Allergol Int. 10.1016/j.alit.2017.03.002. PubMed
  526. An L, et al. 2016. Sci Rep. 6: 33346. PubMed
  527. Wolf J, et al. 2016. J Biol Chem. 291: 16186 - 16196. PubMed
  528. Schneck H, et al. 2015. PLoS One. 10: 0144535. PubMed
  529. Binnewies M, et al. 2019. Cell. 177:556. PubMed
RRID
AB_2818986 (BioLegend Cat. No. 422302)

Antigen Details

Molecular Family
Fc Receptors
Gene ID
NA

Related FAQs

Is our human Trustain FcX™ (cat# 422302) compatible with anti human CD16, CD32 and CD64 clones 3G8, FUN-2 and 10.1 respectively?

Yes

What is the concentration of Human TruStain FcX™ (Fc receptor blocking solution, Cat#422301)?
This information is proprietary.
Go To Top Version: 4    Revision Date: 07.14.2016

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account